| scholarly article | Q13442814 |
| P2093 | author name string | Rui Wang | |
| Ling Liu | |||
| Xiao Ma | |||
| Chengwei Tang | |||
| Libin Huang | |||
| Mingguang Zhang | |||
| Xiaoyan Wan | |||
| Xintong Jia | |||
| Zhiyin Huang | |||
| P2860 | cites work | Cyclooxygenase-2 plays a central role in the genesis of pancreatitis and associated lung injury. | Q45282550 |
| Decreased somatostatin is related to the hypersensitivity of intestinal epithelia to LPS via upregulated TLR4-TBK1 pathway in rats chronically exposed to ethanol | Q46046233 | ||
| The effect of lornoxicam on TLR2 and TLR4 messenger RNA expression and tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion in patients with systemic complications of acute pancreatitis. | Q52951699 | ||
| Comparative evaluation of the modified CT severity index and CT severity index in assessing severity of acute pancreatitis. | Q53211625 | ||
| Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014. | Q53467389 | ||
| Bedside index for severity in acute pancreatitis: comparison with other scoring systems in predicting severity and organ failure. | Q53950899 | ||
| Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-kappaB cytokine pathway. | Q54496421 | ||
| Cytokines and Organ Failure in Acute Pancreatitis | Q58817935 | ||
| Cyclooxygenase and lipoxygenase metabolism in sodium taurocholate induced acute hemorrhagic pancreatitis in rats | Q72971521 | ||
| Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis | Q80149335 | ||
| Prevention of severe acute pancreatitis with octreotide in obese patients: a prospective multi-center randomized controlled trial | Q85242695 | ||
| High-dose versus low-dose octreotide in the treatment of acute pancreatitis: a randomized controlled trial | Q85811806 | ||
| Primary and Secondary Organ Failures Cause Mortality Differentially in Acute Pancreatitis and Should be Distinguished | Q87689202 | ||
| Intravenous or intramuscular parecoxib for acute postoperative pain in adults | Q24241112 | ||
| How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis | Q27008448 | ||
| Immunomodulatory therapies for acute pancreatitis | Q27691380 | ||
| Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis | Q34168659 | ||
| Somatostatin inhibits the production of interferon-γ by intestinal epithelial cells during intestinal ischemia-reperfusion in macaques | Q34174675 | ||
| American College of Gastroenterology guideline: management of acute pancreatitis | Q34360523 | ||
| IAP/APA evidence-based guidelines for the management of acute pancreatitis | Q34372541 | ||
| Flavocoxid, a dual inhibitor of cyclooxygenase‐2 and 5‐lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis | Q34388999 | ||
| Comparison of scoring systems in predicting the severity of acute pancreatitis | Q35128186 | ||
| Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications | Q35361584 | ||
| Somatostatin Improved B Cells Mature in Macaques during Intestinal Ischemia-Reperfusion | Q35723929 | ||
| Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis | Q35861154 | ||
| Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis | Q35883015 | ||
| Role of COX-2 in microcirculatory disturbance in experimental pancreatitis | Q36066240 | ||
| The Role of IL-6, 8, and 10, sTNFr, CRP, and Pancreatic Elastase in the Prediction of Systemic Complications in Patients with Acute Pancreatitis | Q36641146 | ||
| The Atlanta Classification of acute pancreatitis revisited | Q36994308 | ||
| Efficacy and safety of parecoxib sodium for acute postoperative pain: A meta-analysis | Q37207434 | ||
| New insights into the pathogenesis of pancreatitis | Q37602778 | ||
| Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis | Q37764384 | ||
| Somatostatin and octreotide on the treatment of acute pancreatitis - basic and clinical studies for three decades | Q37872808 | ||
| Differential roles of inflammatory cells in pancreatitis. | Q37982806 | ||
| Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation | Q38021899 | ||
| Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus | Q38055715 | ||
| The clinical course of acute pancreatitis and the inflammatory mediators that drive it. | Q39488367 | ||
| Direct medical costs of acute pancreatitis hospitalizations in the United States | Q39826267 | ||
| Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome | Q40431413 | ||
| Clinical relevance of the revised Atlanta classification focusing on severity stratification system | Q41760548 | ||
| Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats | Q41840456 | ||
| Amelioration of the development of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells | Q44082691 | ||
| Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury | Q44165198 | ||
| Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury | Q44180704 | ||
| Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis. | Q44503317 | ||
| COX-2 inhibition results in alterations in nuclear factor (NF)-kappaB activation but not cytokine production in acute pancreatitis | Q44878284 | ||
| Effect of inducible cyclooxygenase expression on local microvessel blood flow in acute interstitial pancreatitis | Q44894316 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 473-480 | |
| P577 | publication date | 2020-03-01 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Prevention of Severe Acute Pancreatitis With Cyclooxygenase-2 Inhibitors: A Randomized Controlled Clinical Trial | |
| P478 | volume | 115 |
Search more.